Send us Feedback

Bellus Health Inc (BLUS)
Analysis
SUMMARY
BULLS
BEARS
Data
DATA CENTRAL
STOCK CHART
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW
QUOTE AND NEWS
Deal buys time to bring kidney disease treatment to market
The Globe and Mail  Apr 6  Comment 
Bellus Health Inc. refinances in exchange for equity, tax credits and deductions
Bellus Health 'pleased' with phase 1 trial of its Alzheimer's drug; stock soars
Canadian Business  Jan 31  Comment 
LAVAL, Que. - Stock in Bellus Health Inc. (TSX:BLU) soared 40 per cent in heavy trading Monday, the same day the company announced positive
Bellus Health to cut two-thirds of its employees over the next year
Canadian Business  Aug 9  Comment 
LAVAL, Que. - Drug development company Bellus Health Inc. said Monday that it plans to gradually lay off more than two-thirds of its workforce
Bellus Health Q1 loss drops to $4.2M from $12.3M on lower overall expenses
Canadian Business  May 12  Comment 
LAVAL, Que. - Bellus Health Inc. said Wednesday it reduced its loss nearly 70 per cent in the first quarter, thanks to lower overall
Bellus to sell amyloidosis drug rights for $10 mln
Reuters  Apr 29  Comment 
Bellus Health Inc said Celtic Therapeutics agreed to buy the rights to its drug candidate to treat a potentially life-threatening condition for upfront payments of $10 million, sending its shares up as much as 47 percent Thursday afternoon.




more ▼WIKI ANALYSIS
 The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article.


 




References

Retrieved from "http://www.wikinvest.com/stock/Bellus_Health_Inc_(BLUS)"
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki